RecruitingPhase 1NCT05962424
HNC: Human Neural Circuits Electrophysiology During Cognition
Sponsor
Stanford University
Enrollment
120 participants
Start Date
Oct 5, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to understand how ketamine brings about dissociative symptoms.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Patient in clinical neuro inpatient units at Stanford Medical Center
- Age >18 years old
- Female participants are expected to use an effective method of birth control throughout the study which includes: hormonal methods (birth control pills, patches, injections, vaginal ring or implants), barrier methods (condom or diaphragm) used with spermicide, intrauterine device (IUD), or abstinence (no sex)
Exclusion Criteria4
- Lifetime psychotic disorder
- Pregnant or nursing females
- Prior adverse ketamine response
- Use of ketamine in past 7 days
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGKetamine Hydrochloride
Ketamine is an FDA-approved dissociative anesthetic.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05962424
Related Trials
Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians
NCT072821581 location
Treating Depression on a Day-to-day Basis: Development of a Tool for Physicians Based on a Smartphone Application
NCT036781941 location
Evaluation of the Efficiency of the PRPP (Perceive, Recall, Plan and Perform) Task Analysis System on Support and Orientation Decisions for People With Aging Psychiatric Disorders (PATPV) Living in Independent Housing.
NCT067387841 location
Investigating the Pathophysiological Nature of Homosexuality
NCT058971771 location
Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness
NCT063767342 locations